Jazz Pharmaceuticals plc
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that company management will participate in fireside chats at the following investor…
Company newsroom
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
3 releases
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results
– Broad commercial execution drives record quarterly revenues of $1.2 billion (+10% YoY) – – Company raises full year 2026 total revenue guidance – –…
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals to Highlight Neuro-Oncology Clinical Research at SNO 2026
Presentations showcase Phase 3 ACTION trial progress and continued development of novel therapies for rare brain cancers For U.S. media and investors…